Good to catch up with you again Holmesearth01 at the AGM. A few...

Good to catch up with you again Holmesearth01 at the AGM.

A few of my notes :

BBraun delayed launch as they required regulatory approval for the blue tooth attached to the blood glucose monitor (which already has approval). This can take 5 or 6 months (from March). The good news is that it will be a global rollout as opposed to a German centric rollout. The product is distributed through 80 countries however each individual country is independent and will decide whether they wish to roll with it.

Beurer are a medical device manufacturer which is privately owned and they are also in 80 plus countries. The apps associated with their devices are not regulatory approved and are looking to use the Bodytel platform which is.

Roche in Germany are looking to use Bodytel for their anticoagulation checking device which checks for blood thickness. Their are 82 million people in Germany with 600k on the warfarin drug. Roche has 200k of those but they want the whole 600k. Roche wants patients to self medicate and to connect patients to the doctor via Bodytel. Roche wants to start with Bodytel with this first product and then branch to others such as diabetes. Roche is the largest manufacturer of medical devices in the world so to get in the front door is a huge advantage/opportunity.

Ehealth. Bodytel are the only ones who can supply medically certified data. Google, Apple, Samsung and others entering this space cannot. If its not medically certified then doctors can't use the data. Pathologists would like to communicate with doctors and Bodytel can do it. This is a massive market. It is very possible if the abovementioned players want to truly attack the E Helath market segment they could save years of development time and time obtaining the necessary regulatory approvals by just taking over Lifespot.

The impression I get is that Bodytel is in a unique position of first mover advantage in the many massive health markets of Internet of Things and has well established connections to make it happen. The lead times on these deals and any future deals appear to be lengthier than most here anticipated and I think the shareprice is reflecting that as well as the liquidation of a lot of small funds holdings who have blown up after the last 6 months micro cap bear market and are suffering redemptions. However the company is well funded with a low cash burn and once the deals come to fruition there should be a snowball effect.

Once we see the BBraun deal kick off which won't be until early the 4th quarter (hopefully no more delays) then that will provide significant proof that the Bodytel system is the real deal. However, their seems to be many other irons in the fire which could hit paydirt in the meantime. At the current low EV you can get in at the basement level of a company that has laid the groundwork over many years of hard work to be in the box seat position in the global digital health industry in partnership with the global health device giants. IMO.

At some stage soon the dumping will end and the registry will tighten right up.